Cabotegravir implant (Preclinical) |
Microbicides, PrEP |
Pre-clinical |
|
United States of America |
Men |
Cabotegravir (GSK 744) |
Completed |
IPM 056 / CCN019B |
Multipurpose Prevention Technologies, PrEP |
I/II |
June 2022 |
United States of America |
Women |
Dapivirine-Levonorgestrel ring |
Ongoing |
EBONI |
PrEP |
IV |
August 2022 |
|
Transgender women, Women |
Cabotegravir (GSK 744) |
Ongoing |
HVTN 141/ HPTN 105 |
PrEP |
Open Label |
March 2023 |
|
Men, Women |
|
|
Purpose 4/ HPTN 103 |
PrEP |
Open Label |
|
|
Injecting drug users |
Lenacapavir |
Planned |
PURPOSE 3/ HPTN 102 |
PrEP |
Open Label |
|
|
Women |
Lenacapavir , TDF/FTC (Truvada) |
Planned |
HPTN 074 |
PrEP, Treatment |
Open Label, III |
February 2015 |
Indonesia, Ukraine, Thailand |
HIV positive, Injecting drug users |
|
Completed |
HPTN 091 |
PrEP |
Open Label |
March 2021 |
United States of America, Brazil |
Men |
TAF/FTC (Descovy), TDF/FTC (Truvada) |
|
HPTN 096 |
General, PrEP, Treatment |
Open Label, Other |
April 2022 |
|
HIV positive, MSM |
|
Ongoing |
HPTN 094/ INTEGRA |
General, PrEP, Treatment |
Demo Project, Open Label |
June 2021 |
United States of America |
HIV positive, Injecting drug users, Men, Women |
|
Ongoing |
PURPOSE 2 |
PrEP |
III |
June 2021 |
United States of America |
Men, MSM, Transgender men, Transgender women |
Lenacapavir , F/TDF |
Ongoing |
Impower 024 |
PrEP |
III |
March 2021 |
|
Men, MSM, Transgender women |
Islatravir (MK-8591) |
Stopped Early |
Impower 022 |
PrEP |
III |
February 2021 |
United States of America, South Africa |
Women |
Islatravir (MK-8591), TDF/FTC (Truvada) |
Stopped Early |
SSPN formulations of novel emtricitabine |
PrEP |
Pre-clinical |
|
|
|
emtricitabine |
|
Transdermal Delivery System for Tenofovir Alafenamide |
PrEP |
Pre-clinical |
|
|
|
F/TAF |
Stopped Early |
CAPRISA 018 |
PrEP |
I |
January 2017 |
|
Women |
tenofovir |
Ongoing |
MK-8591-016 |
PrEP |
II |
September 2019 |
United States of America, Malawi, South Africa, Israel |
Men |
Islatravir (MK-8591) |
Stopped Early |
CONRAD A15-140 |
Microbicides, PrEP |
I |
April 2016 |
United States of America |
Women |
TFV ring, TDF/FTC (Truvada) |
Completed |
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian transgender women (PrEParadas) |
PrEP |
Demo Project |
July 2018 |
Brazil |
|
|
Ongoing |
MTN-041/ MAMMA |
Microbicides, PrEP |
Other |
May 2018 |
Malawi, South Africa, Uganda, Zimbabwe |
Women |
Dapivirine Ring, TDF/FTC (Truvada) |
Ongoing |